MedTrace Logo

Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

NCT02210650 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-05-25

No results posted yet for this study

Summary

Patients with a ureteral or kidney stone that causes symptoms, like pain, frequently have small kidney stones that don't cause symptoms. If these small kidney stones are determined to be asymptomatic (not causing any problems or pain), then most urologists will simply remove the symptomatic ureteral stone and leave the additional stones in the kidneys. However, symptomatic kidney stones started as small stones that didn't cause symptoms. This means that the small stones remaining in the patient's kidney may cause problems later. The purpose of our research is to test if removing small stones from the kidney prevents future stone episodes.

Conditions

  • Ureteral Stones, Kidney Stones

Interventions

PROCEDURE

Symptomatic stone removal

Symptomatic stone removal by the surgical procedures called Ureteroscopy or Percutaneous Nephrolithotomy

PROCEDURE

Asymptomatic kidney stones and ureteral stone removed

Asymptomatic kidney stones and symptomatic stone removal by the surgical procedure called Ureteroscopy

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • VA Puget Sound Health Care System

    collaborator FED

  • Indiana Kidney Stone Institute

    lead OTHER

Principal Investigators

  • James E Lingeman, MD · Indiana University Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02210650 on ClinicalTrials.gov